Skip to main content

Table 3 Intra– and postoperative outcomes of matched cohort with and without a prolonged length of stay

From: Sugammadex is associated with shorter hospital length of stay after open lobectomy for lung cancer: a retrospective observational study

 

LOS ≤ 14 Days

LOS > 14 Days

Pyridostigmine (n = 83)

Sugammadex (n = 93)

p value

Pyridostigmine (n = 44)

Sugammadex (n = 34)

p value

Surgery time (min)

210.0 (180.0–240.0)

205.0 (175.0–240.0)

0.230

240.0 (210.0–270.0)

235.0 (185.0–255.0)

0.457

PCA

 Epidural

72 (86.7)

62 (66.7)

0.003

38 (86.4)

28 (82.4)

0.865

 Intravenous

11 (13.3)

31 (33.3)

 

6 (13.6)

6 (17.6)

 

LOS (days)

10.0 (9.0–12.0)

9.0 (7.0–10.0)

0.002

19.0 (16.0–26.0)

19.0 (16.0–23.0)

0.537

PACU stay (min)

60.0 (55.0–75.0)

60.0 (55.0–75.0)

0.611

70.0 (60.0–90.0)

60.0 (55.0–75.0)

0.007

Events in PACU

 Dyspnea

1 (1.2)

2 (2.2)

1.000

3 (6.8)

1 (2.9)

0.801

 HDI

4 (4.8)

3 (3.2)

0.878

3 (6.8)

1 (2.9)

0.801

Events in ward

 Pyrexia

21 (25.3)

16 (17.2)

0.258

17 (38.6)

12 (35.3)

0.947

 Dyspnea

5 (6.0)

4 (4.3)

0.861

12 (27.3)

6 (17.6)

0.466

 Air leak > 5 days

3 (3.6)

6 (6.5)

0.610

24 (54.5)

19 (55.9)

1.000

 Atelectasis

21 (25.3)

11 (11.8)

0.034

17 (38.6)

12 (35.3)

0.947

 Pneumonia

0 (0.0)

1 (1.1)

1.000

9 (20.5)

5 (14.7)

0.720

 MV

1 (1.2)

0 (0.0)

0.954

2 (4.5)

2 (5.9)

1.000

 HDI

3 (3.6)

0 (0.0)

0.206

4 (9.1)

1 (2.9)

0.526

 ICU

1 (1.2)

0 (0.0)

0.954

4 (9.1)

2 (5.9)

0.921

  1. Data are presented as n (%) or median (interquartile range)
  2. PCA Patient controlled analgesia, LOS Length of stay, PACU Post anesthesia care unit, MV Mechanical ventilator use, HDI Hemodynamic instability, ICU Intensive care unit admission